Drugplain

Piper Methysticum 500 [hp_C]/1

Piper Methysticum · PELLET · Hahnemann Laboratories, INC.

No Recall History
Plain English

Piper Methysticum is a pellet containing piper methysticum at 500 [hp_C]/1, taken oral. Manufactured by Hahnemann Laboratories, INC..

Key Facts

Brand Name
Piper Methysticum
Generic Name
Piper Methysticum
NDC Code (Product)
37662-2352
Manufacturer
Hahnemann Laboratories, INC.
Strength
500 [hp_C]/1
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
01/12/2023

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use3 reports
completed suicide2 reports
covid-192 reports
diarrhoea2 reports
drug ineffective2 reports
hypovolaemic shock2 reports
intestinal ischaemia2 reports
ischaemic hepatitis2 reports
nasopharyngitis2 reports
retroperitoneal haemorrhage2 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Relieves agitation due to mental overactivity during night and day * Uses: See symptoms on front panel.

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Frequently Asked Questions

What is Piper Methysticum used for?

Piper Methysticum contains Piper Methysticum. It is a pellet taken oral. Consult your doctor for specific uses.

Is Piper Methysticum a controlled substance?

Piper Methysticum is not classified as a controlled substance by the DEA.

What is the generic name for Piper Methysticum?

The generic name for Piper Methysticum is Piper Methysticum. There are no other listed brand versions of Piper Methysticum.

What is the NDC code for Piper Methysticum 500 [hp_C]/1?

The NDC (National Drug Code) for Piper Methysticum 500 [hp_C]/1 is 37662-2352, listed by Hahnemann Laboratories, INC..

Product NDC

37662-2352

Package NDC

37662-2352-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)